Mobile Menu

Search Results

Search results for: Precision Oncology

Molecular Analysis for Precision Oncology ONLINE

Oncological care increasingly relies on molecular tumor characterization techniques to enhance patient outcomes. However, the clinical utility of some of these methods remains uncertain, potentially affecting their integration into healthcare systems. With all these new advancements, it can be challenging to stay up to date on the clinical applications and future prospects of these precision oncology techniques.

Join us for our latest webinar series, Molecular Analysis for Precision Oncology ONLINE, where we’ll hear insights from nine leading experts in the cancer genomics field, covering cutting-edge tumour characterisation techniques and their clinical applications.

Base and Prime Genome Editing in Precision Oncology

This feature on prime and base editing is adapted from content provided in the Cancer Genomics 2023 Report. The introduction […]

Advances in Precision Oncology for Blood Cancers

At the heart of precision oncology lies the integration of various disciplines, including genomics, molecular biology, bioinformatics and clinical research. […]

Cancer immunotherapy and precision oncology

In a healthy individual, the immune system responds to “foreign” cells (such as cancer) by attacking and eliminating them. Unfortunately, […]

Precision Oncology ONLINE – September 2022

Join us for this unique three-part webinar series, Precision Oncology ONLINE, as we delve into how detecting rare sequences can […]

Precision Oncology ONLINE – 2021 Edition

Imagine a world where nearly every cancer patient was diagnosed early, at a treatable stage, had access to targeted therapies […]

Evaluation of ctDNA assays for precision oncology

An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]

Precision Oncology ONLINE: From preanalytical considerations to digital insights

Cancer is the world’s second biggest killer. In 2018, cancer claimed the lives of an estimated 9.6 million people. Needless […]

New class of precision oncology drug strips cancer of its DNA defences

Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]

Whole genome, whole exome or panel sequencing in precision oncology clinical trials

With a wealth of genomic technologies rapidly advancing with falling cost, implementing genomics into trials and routine care is becoming […]